Covid variants still transmissible between species, reveals study

Scientists believe bats first transmitted SARS-CoV-2 to humans in December 2019, and the virus has since evolved into several variants such as Delta and Omicron

coronavirus
Photo: Bloomberg
Press Trust of India Washington
2 min read Last Updated : Dec 05 2022 | 2:02 PM IST

The SARS-CoV-2 virus is still highly transmissible between mammals, according to a study based on computer simulations.

Researchers at Rochester Institute of Technology (RIT), US, found that coronaviruses use their spike proteins -- which help them to infect cells -- to attach themselves to the host cells in both bats and humans in much the same way.

The findings, published in the journal Royal Society Open Science, show how the viral spike proteins in several SARS-CoV-2 variants interact with the host cell receptors known as ACE2 in both humans and various bats of genus Rhinolophus.

"We were hoping to see really cool adaptive evolution happening as the virus got more used to humans and less used to bats, but we actually saw that there wasn't a whole lot of change," said Associate Professor Gregory Babbitt from RIT.

"Because this binding site has not evolved very much, there's really not much stopping it from transmitting from humans to bats," Babbit said in a statement.

Scientists believe bats first transmitted SARS-CoV-2 to humans in December 2019, and the virus has since evolved into several variants such as Delta and Omicron.

The study suggests that there would be pretty widespread cross-species infectivity, and the literature has shown there has been a lot of evidence of that.

The researchers used a computer simulation method called molecular dynamics to put proteins in a solvated simulation and then watch them move.

The approach uses high performance computing on graphics processors to show what every atom does over time.

Babbitt said this approach allows scientists to study questions that cannot be answered in a traditional laboratory.

"It would be dangerous to do experiments where we reinfected bats with human viral strains, so our computer-based simulations offered a much safer alternative," Babbitt added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusVirusesCase study

First Published: Dec 05 2022 | 2:02 PM IST

Next Story